Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

Abstract

The addition of an angiotensin converting enzyme inhibitor, enalapril, to conventional therapy, significantly reduced mortality and hospitalizations for heart failure in patients with congestive heart failure and reduced ejection fraction.